Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
申请人:John Varghese
公开号:US20050239832A1
公开(公告)日:2005-10-27
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
2-Amino- and 2-thio- substituted 1,3-diaminopropanes
申请人:Hom Roy
公开号:US20050267199A1
公开(公告)日:2005-12-01
Disclosed are compounds of the formula:
where variables Q, Z, X, R
15
, R
2
, R
3
, and R
c
are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
Disclosed are compounds of the formula:
1
where variables Z, X, R
15
, R
2
, R
3
, and R
c
are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
2-amino- and 2-thio- substituted 1,3-diaminopropanes
申请人:Elan Pharmaceuticals, Inc.
公开号:US07544717B2
公开(公告)日:2009-06-09
Disclosed are compounds of the formula:
where variables Q, Z, X, R15, R2, R3, and Rc are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
Disclosed are compounds of the formula:
where variables Z, X, R
15
, R
2
, R
3
, and R
c
are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.